Position in VKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$153,598,520
+$9,376,620 QoQ
Shares Held
3,937,414
-11.2% QoQ
Ownership
3.38%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#6
of 435 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. VKTX ranks #11 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in VKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $153,598,520 | 3,937,414 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $144,221,900 | 4,432,142 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $85,689,227 | 2,435,737 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $54,806,598 | 2,085,487 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $34,815,249 | 1,313,783 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,265,798 | 52,414 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $3,263,377 | 51,546 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,845,682 | 53,682 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,989,372 | 60,846 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,213,585 | 118,946 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,843,363 | 618,190 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,794,810 | 419,174 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,583,488 | 695,705 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,892,767 | 1,265,188 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,682,798 | 986,323 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,011,385 | 1,042,002 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,732,276 | 1,244,092 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,294,012 | 933,481 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,503,314 | 876,324 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,959,384 | 827,944 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,101,906 | 1,122,831 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,633,938 | 290,220 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $376,111 | 64,624 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,330,299 | 461,900 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||